Characterization of the immature dendritic cells and cytotoxic cells both expanded after activation of invariant NKT cells with α-galactosylceramide in vivo

Biochemical and Biophysical Research Communications

Volumn 369, Issue 2, 2008, Pages 485-492

  Tamura, Yuki ^a   Teng, Annabelle ^a   Nozawa, Risa ^a   Takamoto Matsui, Yukiko ^a   Ishii, Yasuyuki ^a  

^a RIKEN Center for Integrative Medical Sciences   (Japan)

Author keywords

Galactosylceramide; Cytotoxic cells; IL 10; Immature DCs; Immune tolerance; iNKT cells; Liposome; Regulatory DCs

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; ALPHA2 INTEGRIN; CD180 ANTIGEN; CD45RB ANTIGEN; GLYCOPROTEIN P 15095; INTERLEUKIN 10; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; CELL DIFFERENTIATION; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; GALACTOSYLCERAMIDES; KILLER CELLS, NATURAL; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT;

MUS;

EID: 40849095853     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.02.037     Document Type: Article

References (22)

1. Taniguchi M., Harada M., Kojo S., Nakayama T., and Wakao H. The regulatory role of Vα14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21 (2003) 483-513
2. Kojo S., Seino K., Harada M., Watarai H., Wakao H., Uchida T., Nakayama T., and Taniguchi M. Induction of regulatory properties in dendritic cells by Vα14 NKT cells. J. Immunol. 175 (2005) 3648-3655
3. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
4. Steinman R.M., Hawiger D., and Nussenzweig M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21 (2003) 685-711
5. Wakkach A., Fournier N., Brun V., Breittmayer J.-P., Cottrez F., and Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18 (2003) 605-617
6. Homann D., Jahreis A., Wolfe T., Hughes A., Coon B., van Stipdonk M.J., Prilliman K.R., Schoenberger S.P., and von Herrath M.G. CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells. Immunity 16 (2002) 403-415
7. Qian C., Jiang X., An H., Yu Y., Guo Z., Liu S., Xu H., and Cao X. TLR agonists promote ERK-mediated preferential IL-10 production of regulatory dendritic cells (diffDCs), leading to NK-cell activation. Blood 108 (2006) 2307-2315
8. Cerwenka A., and Lanier L.L. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 1 (2001) 41-49
9. Zanoni I., Granucci F., Foti M., and Ricciardi-Castagnoli P. Self-tolerance dendritic cell (DC)-mediated activation and tissue distribution of natural killer (NK) cells. Immunol. Lett. 110 (2007) 6-17
10. Zhang C., Zhang J., and Tian Z. The regulatory effect of natural killer cells: do "NK-reg cells" exist?. Cell. Mol. Immunol. 3 (2006) 241-254
11. Semino C., Angelini G., Poggi A., and Rubartelli A. NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. Blood 106 (2005) 609-616
12. + and NK lymphocytes in the direct cell-to-cell interaction. Clin. Immunol. 112 (2004) 258-267
13. Chan C.W., Crafton E., Fan H.-N., Flook J., Yoshimura K., Skarica M., Brockstedt D., Dubensky T.W., Stins M.F., Lanier L.L., Pardoll D.M., and Housseau F. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat. Med. 12 (2006) 207-213
14. Pillarisetty V.G., Katz S.C., Bleier J.I., Shah A.B., and DeMatteo R.P. Natural killer dendritic cells have both antigen presenting and lytic function and in response to CpG produce IFN-γ via autocrine IL-12. J. Immunol. 174 (2005) 2612-2618
15. Inoh Y., Kitamoto D., Hirashima N., and Nakanishi M. Biosurfactants of MEL-A increase gene transfection mediated by cationic liposomes. Biochem. Biophys. Res. Commun. 289 (2001) 57-61
16. - murine dendritic cell subsets. J. Immunol. 172 (2004) 4826-4833
17. Hijikata A., Kitamura H., Kimura Y., Yokoyama R., Aiba Y., Bao Y., Fujita S., Hase K., Hori S., Ishii Y., Kanagawa O., Kawamoto H., Kawano K., Koseki H., Kubo M., Kurita-Miki A., Kurosaki T., Masuda K., Nakata M., Oboki K., Ohno H., Okamoto M., Okayama Y., O-Wang J., Saito H., Saito T., Sakuma M., Sato K., Sato K., Seino K., Setoguchi R., Tamura Y., Tanaka M., Taniguchi M., Taniuchi I., Teng A., Watanabe T., Watarai H., Yamasaki S., and Ohara O. Construction of an open-access database that integrates cross-reference information from the transcriptome and proteome of immune cells. Bioinformatics 23 (2007) 2934-2941
18. Divanovic S., Trompette A., Atabani S.F., Madan R., Golenbock D.T., Visintin A., Finberg R.W., Tarakhovsky A., Vogel S.N., Belkaid Y., Kurt-Jones E.A., and Karp C.L. Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nat. Immunol. 6 (2005) 571-578
19. Süss G., and Shortman K. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J. Exp. Med. 183 (1996) 1789-1796
20. Taylor A., Verhagen J., Blaser K., Akdis M., and Akdis C.A. Mechanisms of immune suppression by interleukin-10 and transforming growth factor-β: the role of T regulatory cells. Immunology 117 (2006) 433-442
21. + T cells to CTLA4-Ig and interleukin-10 mediated inhibition in an allogeneic dendritic cell-mixed lymphocyte reaction. Immunology 118 (2006) 216-223
22. Koppelman B., Neefjes J.J., de Vries J.E., and de Waal Malefyt R. Interleukin-10 down-regulates MHC class II αβ peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity 7 (1997) 861-871